Riskpilot← Back to searchSign inGet full accessVALDRES BIOVARME AS
ASActiveOrg 996541525Tveitavegen 16, 2900 FagernesSteam and air conditioning supply · NACE 3530Est. 20113 employees
Revenue 2024
NOK 6,6M
-5% vs 2023
EBITDA margin
24.8%
-54% vs 2023
Equity ratio
28.4%
Financial strength
Net profit 2024
NOK -304K
-125% vs 2023
| Revenue | NOK 6,6M | -5% |
| EBITDA | NOK 1,6M | -54% |
| Net profit | NOK -304K | -125% |
| Total assets | NOK 27,7M | +5% |
| Equity | NOK 7,9M | -4% |
| Employees | 3 | — |
Legal name
VALDRES BIOVARME AS
Org number
996541525
Legal form
Aksjeselskap
NACE code
3530 · Steam and air conditioning supply
Founded
9. februar 2011
Share capital
NOK 525 000
Employees
3 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder og ett styremedlem i fellesskap.
Company purpose
Energiproduksjon og alt som har naturlig tilknytning til dette.
Address
Tveitavegen 16, 2900 Fagernes
Email
annonse@avisa-valdres.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 3 443 | 5 811 | 6 191 | 6 983 | 6 602 |
| Staff expenses | −349 | −446 | −417 | −387 | −407 |
| EBITDA | 1 112 | 2 464 | 3 275 | 3 531 | 1 636 |
| Depreciation & amort. | −751 | −774 | −812 | −887 | −927 |
| EBIT | 361 | 1 690 | 2 463 | 2 644 | 709 |
| Net financials | −614 | −540 | −764 | −1 097 | −1 098 |
| Profit before tax | −253 | 1 149 | 1 699 | 1 547 | −389 |
| Tax | −0 | 160 | 374 | 340 | −86 |
| Net profit | −253 | 990 | 1 325 | 1 206 | −304 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 23 854 | 24 101 | 26 314 | 26 221 | 27 660 |
| Equity | 4 651 | 5 641 | 6 966 | 8 172 | 7 869 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 1 122 | 1 434 | 1 849 | 1 759 | 4 157 |
| Total debt | 19 203 | 18 460 | 19 348 | 18 048 | 19 792 |
EBITDA margin
24.8%
This company
15.8%
Market median
+57% vs market
20202024
Equity ratio
28.4%
This company
38.2%
Market median
-26% vs market
20202024
Return on equity
-3.9%
This company
18.4%
Market median
-121% vs market
20202024
Net profit margin
-4.6%
This company
8.1%
Market median
-157% vs market
20202024
Asset turnover
0.24×
This company
1.12×
Market median
-79% vs market
20202024
Debt / equity
2.52×
This company
0.62×
Market median
-306% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Chairman | 2016 | |
| Board of Directors | 2016 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 40% | 40% | 2022 | |
| Company | 20% | 20% | 2022 | |
| Individual | 20% | 20% | 2022 | |
| Individual | 15% | 15% | 2022 | |
| Individual | 5% | 5% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of VALDRES BIOVARME AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Tor Oxhovd Svalesen | Chairman | 0 companies |
| Tor Erik Grønolen | Board of Directors | 0 companies |